MedChunk
Medically reviewed

Macular Degeneration Types: Dry, Wet, and Stages

Learn the differences between dry and wet macular degeneration, the three stages of AMD, how vision changes, and why the type and stage matter for treatment.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateJul 6, 2025 12 min read

There are two main types of age-related macular degeneration (AMD): dry AMD and wet AMD. Dry AMD is more common and usually develops slowly, while wet AMD can cause vision loss more quickly. AMD is also classified into early, intermediate, and late stages based on changes in the retina, the light-sensitive tissue at the back of the eye.

Knowing the difference between the types and stages helps explain why some people have no noticeable vision problems while others have difficulty reading, recognizing faces, or seeing details straight ahead. It also helps eye specialists decide how closely to monitor the condition and which treatments may be appropriate.

How Are Dry and Wet Macular Degeneration Different?

Both types of AMD affect the macula, the small central part of the retina responsible for sharp, detailed vision. However, they damage this area in different ways.

Dry macular degeneration

Dry AMD, also called atrophic macular degeneration, develops as the macula gradually becomes thinner and its light-sensitive cells deteriorate. Small yellow deposits called drusen may also collect beneath the retina.

Dry AMD is the most common form of the condition. Changes often develop over several years, although the rate of progression varies. Some people maintain useful central vision for a long time, while others eventually develop significant vision loss.

According to Mayo Clinic, dry macular degeneration may affect one or both eyes, and central vision can gradually worsen as tissue in the macula loses cells. Side vision generally remains intact.

Wet macular degeneration

Wet AMD, also known as neovascular macular degeneration, occurs when abnormal blood vessels grow beneath or into the retina near the macula. These fragile vessels can leak fluid or blood, damaging the tissue needed for clear central vision.

Wet AMD is less common than dry AMD but can progress much faster. Vision changes may develop over days or weeks, making prompt assessment important.

As explained by Mayo Clinic, wet AMD can cause distorted vision, a blurry area in the center of sight, or difficulty recognizing faces. Early detection and treatment may help limit further vision loss and, in some cases, improve vision.

Dry vs. Wet AMD: Key Differences

The most important distinction is how the macula is damaged and how quickly vision may change.

Feature Dry AMD Wet AMD
How common is it? More common Less common
Main change in the eye Thinning and deterioration of macular tissue Abnormal blood vessel growth and leakage
Typical progression Usually gradual, often over years Can worsen rapidly, sometimes within days or weeks
Stages Early, intermediate, and late Always classified as late AMD
Possible vision changes Gradual blurring, difficulty in dim light, or central blind spots in advanced disease Rapid distortion, blurred central vision, or new central blind spots
Treatment approach Monitoring, selected supplements, and stage-specific care Usually anti-VEGF injections to control abnormal blood vessels

Neither type typically causes complete blindness because AMD primarily affects central vision rather than peripheral, or side, vision. However, advanced disease can substantially interfere with everyday activities.

What Are the Three Stages of Macular Degeneration?

Age-related macular degeneration is commonly divided into three stages: early, intermediate, and late. These classifications describe changes found during an eye examination, not simply how blurry a person's vision feels.

The National Eye Institute (NEI) explains that dry AMD can occur at all three stages, while wet AMD is considered a form of late AMD. Early disease may cause no symptoms, which is why retinal examinations are important.

Stage 1: Early macular degeneration

Early AMD is characterized by changes in the retina, including medium-sized drusen beneath the macula. These deposits are usually identified during a dilated eye examination rather than through noticeable symptoms.

People with early AMD generally have normal central vision and can often continue reading, driving, and performing detailed tasks without difficulty.

At this stage, the purpose of regular eye examinations is to identify changes before more advanced damage develops. Treatment usually focuses on monitoring and supporting overall eye health.

Stage 2: Intermediate macular degeneration

Intermediate AMD involves more noticeable retinal changes, such as larger drusen, changes in retinal pigmentation, or both.

Some people continue to see normally, while others begin experiencing difficulty with fine details or low-light conditions.

Possible changes include:

  • Mild blurring in the center of vision.
  • Greater difficulty reading in dim lighting.
  • Needing brighter light for close-up activities.
  • Reduced ability to distinguish fine details.

These changes do not necessarily mean AMD has advanced to a late stage. An ophthalmologist determines the stage by examining the retina and, when needed, using retinal imaging.

Intermediate AMD is especially important because certain vitamin and mineral supplements, known as AREDS2 supplements, may reduce the risk of progression to late AMD in eligible patients.

Stage 3: Late macular degeneration

Late AMD occurs when damage to the macula becomes advanced enough to threaten or reduce central vision. It has two main forms: geographic atrophy and neovascular AMD.

Geographic atrophy (advanced dry AMD): Areas of retinal cells and supporting tissue gradually deteriorate. As these areas expand, central vision may become increasingly blurred or develop missing spots.

Neovascular AMD (wet AMD): Abnormal blood vessels develop and leak beneath or within the retina. This can cause relatively rapid distortion or loss of central vision.

Late AMD may affect one eye or both eyes. The stage can also differ between eyes, meaning a person may have intermediate AMD in one eye and late AMD in the other.

Is Geographic Atrophy the Same as Dry Macular Degeneration?

Geographic atrophy is a specific advanced form of dry AMD, not another name for every stage of dry macular degeneration.

In early or intermediate dry AMD, the retina may show drusen or pigment changes without extensive tissue loss. Geographic atrophy develops when areas of the light-sensitive retina and its supporting layers are lost.

The location and extent of this damage affect how much vision is impaired. If the damaged area involves the center of the macula, activities such as reading small print or recognizing faces may become especially difficult.

Geographic atrophy generally progresses over time, but the pattern and rate vary. Although existing tissue damage cannot currently be reversed, specialist treatment options intended to slow lesion progression are available in some countries for certain patients. Availability and suitability depend on local approval and individual clinical circumstances.

Can Dry Macular Degeneration Turn Into Wet AMD?

Yes. Dry AMD can progress to wet AMD when abnormal blood vessels begin growing near the macula. This change can occur from different stages of dry AMD and does not require geographic atrophy to develop first.

However, not everyone with dry AMD develops wet AMD. Many people remain in the dry form for years without a rapid decline in central vision.

Changes that may occur with wet AMD include:

  • Previously straight lines appearing bent or wavy.
  • A sudden increase in blurriness when looking straight ahead.
  • A new dark, gray, or blank area near the center of vision.
  • Unexpected difficulty reading or recognizing faces.

These symptoms can also occur with other eye conditions, so an examination is needed to determine the cause. A new distortion or sudden change in central vision should be assessed urgently by an eye care professional.

How Do Eye Doctors Determine the Type and Stage?

An ophthalmologist or optometrist assesses macular degeneration using visual testing and a careful examination of the retina. The findings help distinguish dry AMD from wet AMD and identify the extent of retinal changes.

According to the UK National Health Service (NHS), eye examinations may involve looking at the back of the eye with a microscope, using pupil-dilating drops, and performing retinal scans when necessary.

Retinal examination

Dilating the pupils allows an eye specialist to examine the retina more clearly. They look for drusen, pigment changes, areas of tissue loss, and findings that may suggest abnormal blood vessel activity.

Optical coherence tomography (OCT)

OCT is a noninvasive imaging test that produces detailed cross-sectional pictures of the retina. It can show thinning, structural damage, and fluid that may be associated with wet AMD.

Additional imaging when needed

Sometimes, an eye specialist recommends further imaging, such as fluorescein angiography or OCT angiography, to evaluate abnormal blood vessels more closely.

The diagnosis and stage are based on these findings together with visual symptoms, medical history, and changes observed over time.

Does Treatment Depend on the Type or Stage of AMD?

Yes. Treatment decisions depend on whether AMD is dry or wet, how advanced the retinal changes are, and whether useful vision is being threatened.

Early dry AMD

Early AMD usually does not require a specific medical treatment. Periodic eye examinations and attention to modifiable risk factors are the main approaches.

Intermediate dry AMD

For selected people with intermediate AMD, AREDS2 supplements may lower the risk of progression to advanced disease. These supplements do not restore lost vision and are not recommended for every person with AMD.

An eye specialist can determine whether they are appropriate based on retinal findings and the condition of each eye.

Late dry AMD

Management of advanced dry AMD may include low-vision rehabilitation, assistive devices, and ongoing retinal monitoring. For geographic atrophy, certain specialist treatments may be considered where approved and available, although they do not restore lost retinal cells.

Wet AMD

Wet AMD often requires treatment aimed at controlling abnormal blood vessel growth and leakage. Anti-VEGF medicines, delivered by injections into the eye, are the primary treatment approach.

The U.S. National Library of Medicine's MedlinePlus explains that these injections may slow or stop further vision loss and can sometimes improve vision. Photodynamic therapy, which combines medication with laser light, may also be used in selected cases.

Wet AMD commonly requires follow-up appointments and repeated treatments to control disease activity.

Do All Stages of AMD Lead to Serious Vision Loss?

No. Having early or intermediate macular degeneration does not mean that severe vision loss is inevitable.

Some people experience little progression over many years. Others develop late dry AMD or wet AMD, which can have a greater impact on central vision.

The future course of AMD cannot be predicted from symptoms alone. The retinal changes, stage of disease, and condition of the other eye provide more useful information for follow-up planning.

Even when central vision becomes significantly affected, peripheral vision generally remains. Magnifiers, brighter lighting, electronic reading tools, and vision rehabilitation can help people make better use of their remaining sight.

What Should You Remember About AMD Types and Stages?

The distinction between dry and wet AMD describes how the macula is damaged, while the stage describes how far the disease has progressed.

Dry AMD is more common and usually progresses gradually through early, intermediate, and late stages. Geographic atrophy is an advanced dry form. Wet AMD is always classified as late-stage disease and may cause faster central vision loss because of leaking abnormal blood vessels.

Regular retinal examinations can identify changes before they become obvious. If straight lines suddenly appear wavy, central vision becomes newly blurred, or a new blind spot develops, prompt eye care is important because some causes, including wet AMD, are time-sensitive and treatable.

Frequently Asked Questions

These answers address common questions about the differences between dry and wet AMD, their stages, and how they affect vision.

Which is more serious, dry or wet macular degeneration?

Wet AMD is generally more likely to cause rapid central vision loss because abnormal blood vessels can leak fluid or blood into the retina. However, advanced dry AMD can also cause substantial and permanent central vision impairment. Both types require appropriate monitoring and care.

Can you have early-stage wet macular degeneration?

Wet AMD is classified as late-stage age-related macular degeneration, even when abnormal blood vessel growth is detected before major vision loss occurs. Finding it early in its development is still important because prompt treatment may help preserve vision.

Does intermediate dry AMD always progress to late AMD?

No. Some people with intermediate AMD remain stable for years, while others progress to geographic atrophy or wet AMD. Retinal findings help eye specialists assess risk and determine whether AREDS2 supplements or closer monitoring may be beneficial.

Can one eye have dry AMD while the other has wet AMD?

Yes. The two eyes can have different types or stages of AMD. One eye may have intermediate dry AMD while the other develops wet AMD. Eye specialists therefore assess and monitor each eye separately.

Is late-stage macular degeneration the same as blindness?

No. Late AMD can severely affect central vision, making reading, driving, and recognizing faces difficult. However, peripheral vision usually remains. Low-vision services and assistive tools may help maintain independence and daily functioning.

Citations

  1. Mayo Clinic — Dry Macular Degeneration: Symptoms and Causes
  2. Mayo Clinic — Wet Macular Degeneration: Symptoms and Causes
  3. National Eye Institute — Age-Related Macular Degeneration (AMD)
  4. NHS — Age-Related Macular Degeneration: Getting Diagnosed
  5. MedlinePlus — Macular Degeneration
Share this article